Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $1.13 Million - $1.26 Million
-4,890 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $149,796 - $166,009
675 Added 16.01%
4,890 $1.22 Million
Q3 2020

Nov 16, 2020

BUY
$215.77 - $276.76 $74,440 - $95,482
345 Added 8.91%
4,215 $981,000
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $332,049 - $397,749
1,510 Added 63.98%
3,870 $926,000
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $11,741 - $16,740
60 Added 2.61%
2,360 $542,000
Q4 2019

Feb 13, 2020

BUY
$236.45 - $266.82 $59,112 - $66,705
250 Added 12.2%
2,300 $626,000
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $108,700 - $123,040
500 Added 32.26%
2,050 $517,000
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $98,904 - $119,121
480 Added 44.86%
1,550 $387,000
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $219,061 - $275,985
1,070 New
1,070 $241,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Guardian Capital LP Portfolio

Follow Guardian Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital LP with notifications on news.